Eton Pharmaceuticals (ETON) EPS (Basic) Growth (5y) (2023 - 2026)
Eton Pharmaceuticals (ETON) EPS (Basic) Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.87 Bn | 2.15 Bn |
| 3 | Zoetis | 32.47 Bn | 30.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.38 Bn | 19.71 Bn | 683.80 Mn |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.90 Bn | 11.37 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Eton Pharmaceuticals | 1.71 Bn | 1.69 Bn | 25.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.57% |
| Dec 31, 2025 | 16.78% |
| Sep 30, 2025 | 25.34% |
| Jun 30, 2025 | 94.68% |
| Mar 31, 2025 | 34.87% |
| Dec 31, 2024 | 31.38% |
| Sep 30, 2024 | 145.50% |
| Jun 30, 2024 | -264.55% |
| Mar 31, 2024 | -136.73% |
| Dec 31, 2023 | 55.27% |
| Sep 30, 2023 | 48.93% |
| Jun 30, 2023 | 17.34% |
| Mar 31, 2023 | 36.98% |